Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Kontigo Care AB (publ) (3KT.F)

0.1475
-0.0130
(-8.10%)
As of 8:16:10 AM GMT+2. Market Open.
Loading Chart for 3KT.F
  • Previous Close 0.1605
  • Open 0.1475
  • Bid 0.1965 x --
  • Ask 0.2650 x --
  • Day's Range 0.1475 - 0.1475
  • 52 Week Range 0.1220 - 0.2770
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 6.32M
  • Beta (5Y Monthly) 0.01
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Kontigo Care AB (publ) provides health care solutions for addiction treatment in Sweden. It offers Previct Alcohol, a digital medical device for the treatment of alcohol addiction; Previct Gamble, a digital tool for the treatment of gambling addiction; Previct Drugs, a digital platform to stop drug addiction; Previct Mind, a modern tool used as support in the treatment of mental illness; Previct Family, a tool for the whole family when the whole family is in contact with a therapist for family's well-being; Previct Work, a digital supports that are used in addiction care at the workplace. The company was incorporated in 2013 and is based in Uppsala, Sweden.

www.kontigocare.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 3KT.F

View More

Performance Overview: 3KT.F

Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

3KT.F
14.49%
OMX Stockholm 30 Index (^OMX)
4.79%

1-Year Return

3KT.F
2.64%
OMX Stockholm 30 Index (^OMX)
5.86%

3-Year Return

3KT.F
72.17%
OMX Stockholm 30 Index (^OMX)
12.85%

5-Year Return

3KT.F
51.48%
OMX Stockholm 30 Index (^OMX)
54.76%

Compare To: 3KT.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3KT.F

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    6.88M

  • Enterprise Value

    5.24M

  • Trailing P/E

    59.51

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.83

  • Price/Book (mrq)

    1.20

  • Enterprise Value/Revenue

    1.93

  • Enterprise Value/EBITDA

    11.51

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.92%

  • Return on Assets (ttm)

    0.93%

  • Return on Equity (ttm)

    1.87%

  • Revenue (ttm)

    40.47M

  • Net Income Avi to Common (ttm)

    775k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.86M

  • Total Debt/Equity (mrq)

    7.02%

  • Levered Free Cash Flow (ttm)

    -9.18M

Research Analysis: 3KT.F

View More

Company Insights: 3KT.F

Research Reports: 3KT.F

View More